Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

118 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Comprehensive next-generation sequencing identifies novel putative pathogenic or likely pathogenic germline variants in patients with concurrent tubo-ovarian and endometrial serous and endometrioid carcinomas or precursors.
Aisagbonhi O, Ghlichloo I, Hong DS, Roma A, Fadare O, Eskander R, Saenz C, Fisch KM, Song W. Aisagbonhi O, et al. Among authors: eskander r. Gynecol Oncol. 2024 Jun 3;187:241-248. doi: 10.1016/j.ygyno.2024.05.027. Online ahead of print. Gynecol Oncol. 2024. PMID: 38833993
ACR Appropriateness Criteria® Clinically Suspected Adnexal Mass, No Acute Symptoms: 2023 Update.
Expert Panel on GYN and OB Imaging; Patel-Lippmann KK, Wasnik AP, Akin EA, Andreotti RF, Ascher SM, Brook OR, Eskander RN, Feldman MK, Jones LP, Martino MA, Patel MD, Patlas MN, Revzin MA, VanBuren W, Yashar CM, Kang SK. Expert Panel on GYN and OB Imaging, et al. Among authors: eskander rn. J Am Coll Radiol. 2024 Jun;21(6S):S79-S99. doi: 10.1016/j.jacr.2024.02.017. J Am Coll Radiol. 2024. PMID: 38823957
ARID1A suppresses R-loop-mediated STING-type I interferon pathway activation of anti-tumor immunity.
Maxwell MB, Hom-Tedla MS, Yi J, Li S, Rivera SA, Yu J, Burns MJ, McRae HM, Stevenson BT, Coakley KE, Ho J, Gastelum KB, Bell JC, Jones AC, Eskander RN, Dykhuizen EC, Shadel GS, Kaech SM, Hargreaves DC. Maxwell MB, et al. Among authors: eskander rn. Cell. 2024 May 9:S0092-8674(24)00451-3. doi: 10.1016/j.cell.2024.04.025. Online ahead of print. Cell. 2024. PMID: 38754421
Top advances of the year: Uterine cancer.
Erickson BK, Slomovitz B, Powell M, Eskander RN. Erickson BK, et al. Among authors: eskander rn. Cancer. 2024 Apr 15. doi: 10.1002/cncr.35321. Online ahead of print. Cancer. 2024. PMID: 38620054
Viewing the immune checkpoint VISTA: landscape and outcomes across cancers.
Nishizaki D, Kurzrock R, Miyashita H, Adashek JJ, Lee S, Nikanjam M, Eskander RN, Patel H, Botta GP, Nesline MK, Pabla S, Conroy JM, DePietro P, Sicklick JK, Kato S. Nishizaki D, et al. Among authors: eskander rn. ESMO Open. 2024 Apr;9(4):102942. doi: 10.1016/j.esmoop.2024.102942. Epub 2024 Mar 18. ESMO Open. 2024. PMID: 38503143 Free PMC article.
Recent Therapeutic Advances in Gynecologic Oncology: A Review.
Wilson EM, Eskander RN, Binder PS. Wilson EM, et al. Among authors: eskander rn. Cancers (Basel). 2024 Feb 13;16(4):770. doi: 10.3390/cancers16040770. Cancers (Basel). 2024. PMID: 38398161 Free PMC article. Review.
118 results